Physician profile
Hailey Day
NPI 1811718455
$683.22
in general payments reported to CMS, 2019-2025
17 companies · $663 in 2025
The $663 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $20.20 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.86 | 2025 | Xifaxan |
| Pfizer INC. | $109.10 | 2025 | |
| Abbvie INC. | $98.58 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $52.59 | 2025 | Airsupra |
| Amgen INC. | $43.68 | 2025 | Repatha, Otezla |
| Novo Nordisk INC | $34.83 | 2025 | Ozempic |
| Lundbeck LLC | $27.76 | 2025 | Rexulti |
| Seqirus USA INC | $26.52 | 2025 | Flucelvax, Fluad |
| Axsome Therapeutics, INC. | $24.94 | 2025 | Auvelity |
| Merck Sharp & Dohme LLC | $20.20 | 2024 | Capvaxive, Gardasil 9, Gardasil |
| Dexcom, INC. | $19.57 | 2025 | Dexcom G6 Transmitter |
| Organon LLC | $19.29 | 2025 | Nexplanon |
| Lilly USA, LLC | $19.25 | 2025 | Zepbound |
| Phathom Pharmaceuticals, INC. | $18.37 | 2025 | Voquezna |
| Neurocrine Biosciences, INC. | $17.72 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.22 | 2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $13.74 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hailey Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.